Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 17 | 2025 | 85 | 7.200 |
Why?
|
| Thrombosis | 8 | 2025 | 136 | 3.690 |
Why?
|
| Platelet Activation | 6 | 2023 | 26 | 1.920 |
Why?
|
| Influenza, Human | 2 | 2021 | 161 | 1.150 |
Why?
|
| Hemostasis | 4 | 2020 | 14 | 1.030 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2025 | 33 | 0.930 |
Why?
|
| Leukocytes | 1 | 2025 | 73 | 0.930 |
Why?
|
| Megakaryocytes | 4 | 2022 | 17 | 0.910 |
Why?
|
| Receptor, Adenosine A2B | 7 | 2014 | 9 | 0.890 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 78 | 0.840 |
Why?
|
| Cardiovascular System | 1 | 2023 | 22 | 0.810 |
Why?
|
| Atherosclerosis | 5 | 2014 | 109 | 0.770 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 68 | 0.700 |
Why?
|
| Betacoronavirus | 2 | 2020 | 82 | 0.680 |
Why?
|
| Plague | 1 | 2020 | 22 | 0.670 |
Why?
|
| Yersinia pestis | 1 | 2020 | 32 | 0.670 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 91 | 0.650 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 99 | 0.640 |
Why?
|
| Virion | 1 | 2020 | 103 | 0.640 |
Why?
|
| Immunity, Innate | 2 | 2022 | 662 | 0.610 |
Why?
|
| Pandemics | 2 | 2020 | 331 | 0.580 |
Why?
|
| DNA Viruses | 1 | 2018 | 11 | 0.580 |
Why?
|
| Herpesviridae | 1 | 2018 | 11 | 0.570 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2019 | 72 | 0.570 |
Why?
|
| Influenza A virus | 1 | 2019 | 111 | 0.560 |
Why?
|
| Toll-Like Receptors | 2 | 2020 | 393 | 0.550 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 135 | 0.540 |
Why?
|
| RNA, Viral | 1 | 2018 | 197 | 0.530 |
Why?
|
| Humans | 24 | 2025 | 40217 | 0.510 |
Why?
|
| Apoptosis | 1 | 2021 | 893 | 0.510 |
Why?
|
| MicroRNAs | 2 | 2020 | 535 | 0.500 |
Why?
|
| Membrane Glycoproteins | 2 | 2019 | 586 | 0.480 |
Why?
|
| Animals | 20 | 2023 | 16893 | 0.470 |
Why?
|
| Adenosine | 2 | 2012 | 58 | 0.470 |
Why?
|
| Coxsackievirus Infections | 1 | 2015 | 11 | 0.460 |
Why?
|
| Enterovirus B, Human | 1 | 2015 | 17 | 0.460 |
Why?
|
| Myocarditis | 1 | 2015 | 20 | 0.450 |
Why?
|
| Cardiovirus Infections | 1 | 2014 | 14 | 0.430 |
Why?
|
| Encephalomyocarditis virus | 1 | 2014 | 15 | 0.430 |
Why?
|
| Inflammation | 10 | 2022 | 912 | 0.420 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2012 | 12 | 0.390 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 22 | 0.370 |
Why?
|
| Mice, Knockout | 10 | 2019 | 1772 | 0.360 |
Why?
|
| Male | 10 | 2025 | 18271 | 0.310 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 545 | 0.310 |
Why?
|
| Female | 11 | 2025 | 20392 | 0.300 |
Why?
|
| Mice | 12 | 2023 | 8809 | 0.250 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1691 | 0.250 |
Why?
|
| Neoplasms | 2 | 2025 | 863 | 0.240 |
Why?
|
| Circulating Tumor DNA | 1 | 2025 | 5 | 0.240 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2025 | 7 | 0.240 |
Why?
|
| DNA, Neoplasm | 1 | 2025 | 44 | 0.240 |
Why?
|
| Fetus | 1 | 2025 | 78 | 0.230 |
Why?
|
| Adult | 4 | 2025 | 10255 | 0.230 |
Why?
|
| Neutrophils | 2 | 2019 | 307 | 0.220 |
Why?
|
| Aged | 3 | 2025 | 8182 | 0.220 |
Why?
|
| Blotting, Western | 3 | 2021 | 497 | 0.210 |
Why?
|
| Risk Factors | 3 | 2017 | 3141 | 0.210 |
Why?
|
| Middle Aged | 4 | 2025 | 10090 | 0.210 |
Why?
|
| A549 Cells | 1 | 2021 | 32 | 0.180 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 110 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 503 | 0.170 |
Why?
|
| Hibernation | 1 | 2020 | 10 | 0.170 |
Why?
|
| Ursidae | 1 | 2020 | 12 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 44 | 0.160 |
Why?
|
| Endocytosis | 1 | 2020 | 134 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 103 | 0.160 |
Why?
|
| Blood Vessels | 2 | 2012 | 41 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 207 | 0.150 |
Why?
|
| Complement C3 | 1 | 2019 | 46 | 0.150 |
Why?
|
| Extracellular Traps | 1 | 2019 | 34 | 0.150 |
Why?
|
| Collagen | 2 | 2016 | 87 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 532 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 2708 | 0.140 |
Why?
|
| Dietary Fats | 3 | 2014 | 158 | 0.130 |
Why?
|
| Mean Platelet Volume | 1 | 2017 | 2 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 136 | 0.130 |
Why?
|
| Hypertension | 1 | 2020 | 385 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 165 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 410 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 65 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 106 | 0.130 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2016 | 3 | 0.120 |
Why?
|
| Obesity | 2 | 2014 | 970 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2016 | 10 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2017 | 122 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 668 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 21 | 0.120 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 19 | 0.110 |
Why?
|
| Cell Degranulation | 1 | 2014 | 11 | 0.110 |
Why?
|
| Platelet Count | 1 | 2014 | 17 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 108 | 0.110 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 18 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 191 | 0.110 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 7 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2017 | 328 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 138 | 0.110 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 135 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 239 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2012 | 2581 | 0.100 |
Why?
|
| Sex Factors | 1 | 2015 | 646 | 0.100 |
Why?
|
| Foam Cells | 1 | 2012 | 4 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 236 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 870 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 921 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1254 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2012 | 35 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 3136 | 0.090 |
Why?
|
| Macrophages | 2 | 2014 | 888 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 95 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 38 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2014 | 370 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 38 | 0.090 |
Why?
|
| Biomarkers | 1 | 2015 | 945 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 755 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 305 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 37 | 0.080 |
Why?
|
| Massachusetts | 1 | 2015 | 1701 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 383 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2020 | 290 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1340 | 0.070 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2008 | 9 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 61 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 28 | 0.070 |
Why?
|
| Liver | 1 | 2011 | 704 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 683 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 505 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2006 | 172 | 0.060 |
Why?
|
| Liquid Biopsy | 1 | 2025 | 2 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2025 | 64 | 0.060 |
Why?
|
| Platelet Adhesiveness | 2 | 2016 | 5 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2025 | 539 | 0.050 |
Why?
|
| Nanomedicine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1074 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 85 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 85 | 0.050 |
Why?
|
| Adenosine A2 Receptor Agonists | 2 | 2012 | 6 | 0.040 |
Why?
|
| Antithrombin III | 1 | 2020 | 14 | 0.040 |
Why?
|
| Angiotensins | 1 | 2020 | 3 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 112 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 578 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 1664 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 107 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 1616 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 190 | 0.040 |
Why?
|
| Inpatients | 1 | 2020 | 146 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 346 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1072 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 116 | 0.030 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 194 | 0.030 |
Why?
|
| Integrin alpha2beta1 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2016 | 4 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 7 | 0.030 |
Why?
|
| Platelet Factor 4 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2016 | 333 | 0.030 |
Why?
|
| Bacteroidaceae Infections | 1 | 2014 | 3 | 0.030 |
Why?
|
| Porphyromonas gingivalis | 1 | 2014 | 15 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 51 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 78 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 126 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 419 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 168 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2012 | 11 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 229 | 0.020 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2012 | 3 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 194 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 366 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 53 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 803 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 225 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2010 | 4 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1697 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 119 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 616 | 0.020 |
Why?
|
| NADPH Oxidase 4 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 444 | 0.020 |
Why?
|
| Aorta | 1 | 2008 | 61 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 185 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 823 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 465 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 560 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2006 | 2 | 0.020 |
Why?
|
| P-Selectin | 1 | 2006 | 7 | 0.020 |
Why?
|
| E-Selectin | 1 | 2006 | 17 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 41 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1744 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 352 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 221 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 2422 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 732 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 721 | 0.010 |
Why?
|